{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T14:10:25Z","timestamp":1794924625808,"version":"4.9.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HR18C001202"],"award-info":[{"award-number":["HR18C001202"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008005","name":"Yonsei University College of Medicine","doi-asserted-by":"publisher","award":["6\\u20132023-0167"],"award-info":[{"award-number":["6\\u20132023-0167"]}],"id":[{"id":"10.13039\/501100008005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2021R1A4A1029238"],"award-info":[{"award-number":["NRF-2021R1A4A1029238"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.diabres.2025.112209","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T19:04:02Z","timestamp":1745867042000},"page":"112209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Impact of physical activities in metabolic dysfunction associated steatotic liver disease, sarcopenia, and cardiovascular disease"],"prefix":"10.1016","volume":"224","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3237-3317","authenticated-orcid":false,"given":"Eugene","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sin Yung","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin Y.","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Seok","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bong-Soo","family":"Cha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung-Wan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6219-4942","authenticated-orcid":false,"given":"Yong-ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2025.112209_b0005","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2809\u201317","key":"10.1016\/j.diabres.2025.112209_b0010","first-page":"e28","article-title":"2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis","volume":"20","author":"Le","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.diabres.2025.112209_b0015","doi-asserted-by":"crossref","first-page":"347","DOI":"10.4093\/dmj.2022.0444","article-title":"Fatty Liver & Diabetes Statistics in Korea: Nationwide Data 2009 to 2017","volume":"47","author":"Han","year":"2023","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.diabres.2025.112209_b0020","doi-asserted-by":"crossref","first-page":"430","DOI":"10.4093\/dmj.2017.41.6.430","article-title":"Non-Alcoholic Fatty Liver Disease: The Emerging Burden in Cardiometabolic and Renal Diseases","volume":"41","author":"Han","year":"2017","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.diabres.2025.112209_b0025","doi-asserted-by":"crossref","unstructured":"Lee Y-h, Jung KS, Kim SU, Yoon H-j, Yun YJ, Lee B-W, et al. Sarcopaenia is associated with NAFLD independently of obesity and insulin resistance: Nationwide surveys (KNHANES 2008\u20132011). Journal of Hepatology. 2015;63:486-93.","DOI":"10.1016\/j.jhep.2015.02.051"},{"key":"10.1016\/j.diabres.2025.112209_b0030","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3803\/EnM.2022.102","article-title":"State-of-the-Art Overview of the Pharmacological Treatment of Non-Alcoholic Steatohepatitis","volume":"37","author":"Cho","year":"2022","journal-title":"Endocrinol Metab (Seoul)"},{"key":"10.1016\/j.diabres.2025.112209_b0035","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1136\/bjsports-2020-102955","article-title":"World Health Organization 2020 guidelines on physical activity and sedentary behaviour","volume":"54","author":"Bull","year":"2020","journal-title":"Br J Sports Med"},{"key":"10.1016\/j.diabres.2025.112209_b0040","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/joim.13344","article-title":"Muscle-strengthening activities and risk of cardiovascular disease, type 2 diabetes, cancer and mortality: A review of prospective cohort studies","volume":"290","author":"Giovannucci","year":"2021","journal-title":"J Intern Med"},{"key":"10.1016\/j.diabres.2025.112209_b0045","doi-asserted-by":"crossref","first-page":"232","DOI":"10.4093\/dmj.2021.0355","article-title":"Non-Alcoholic Fatty Liver Disease with Sarcopenia and Carotid Plaque Progression Risk in Patients with Type 2 Diabetes Mellitus","volume":"47","author":"Cho","year":"2023","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.diabres.2025.112209_b0050","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1161\/CIRCULATIONAHA.123.064071","article-title":"Sarcopenia and Cardiovascular Diseases","volume":"147","author":"Damluji","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2025.112209_b0055","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1002\/jcsm.13221","article-title":"Sarcopenia and cardiovascular diseases: A systematic review and meta-analysis","volume":"14","author":"Zuo","year":"2023","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.diabres.2025.112209_b0060","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4093\/dmj.2019.0011","article-title":"Nonalcoholic Fatty Liver Disease in Diabetes Part I: Epidemiology and Diagnosis Diabetes","volume":"43","author":"Lee","year":"2019","journal-title":"Metab J"},{"key":"10.1016\/j.diabres.2025.112209_b0065","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1007\/s00535-018-1474-y","article-title":"The novel cutoff points for the FIB4 index categorized by age increase the diagnostic accuracy in NAFLD: a multi-center study","volume":"53","author":"Ishiba","year":"2018","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.diabres.2025.112209_b0070","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1161\/01.cir.0000437741.48606.98","article-title":"2013 ACC\/AHA Guideline on the Assessment of Cardiovascular Risk","volume":"129","author":"Goff","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2025.112209_b0075","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/gerona\/glu010","article-title":"The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates","volume":"69","author":"Studenski","year":"2014","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.diabres.2025.112209_b0080","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1464-5491.2006.01858.x","article-title":"Metabolic syndrome\u2013a new world-wide definition. A Consensus Statement from the International Diabetes Federation","volume":"23","author":"Alberti","year":"2006","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabres.2025.112209_b0085","unstructured":"WHO. The Asia-Pacific perspective : redefining obesity and its treatment. Sydney: International Diabetes Institute, Regional Office for the Western Pacific; 2000."},{"key":"10.1016\/j.diabres.2025.112209_b0090","doi-asserted-by":"crossref","first-page":"546","DOI":"10.4093\/dmj.2024.0249","article-title":"2023 Clinical Practice Guidelines for Diabetes Management in Korea: Full Version Recommendation of the Korean Diabetes Association","volume":"48","author":"Moon","year":"2024","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.diabres.2025.112209_b0095","doi-asserted-by":"crossref","first-page":"584","DOI":"10.14309\/ajg.0000000000000572","article-title":"Nonalcoholic Fatty Liver Disease and Sarcopenia Are Independently Associated With Cardiovascular Risk","volume":"115","author":"Han","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.diabres.2025.112209_b0100","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1001\/jama.2015.5370","article-title":"Nonalcoholic fatty liver disease: a systematic review","volume":"313","author":"Rinella","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.diabres.2025.112209_b0105","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jhep.2016.08.023","article-title":"Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review","volume":"66","author":"Hashida","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.diabres.2025.112209_b0110","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/liv.13332","article-title":"The preventive effect of sustained physical activity on incident nonalcoholic fatty liver disease","volume":"37","author":"Kwak","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.diabres.2025.112209_b0115","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1136\/heartjnl-2021-320013","article-title":"Association of physical activity trajectories with major cardiovascular diseases in elderly people","volume":"108","author":"Amidei","year":"2022","journal-title":"Heart"},{"key":"10.1016\/j.diabres.2025.112209_b0120","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1249\/MSS.0000000000001822","article-title":"Associations of Resistance Exercise with Cardiovascular Disease Morbidity and Mortality","volume":"51","author":"Liu","year":"2019","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.diabres.2025.112209_b0125","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1136\/bjsports-2021-105061","article-title":"Muscle-strengthening activities are associated with lower risk and mortality in major non-communicable diseases: a systematic review and meta-analysis of cohort studies","volume":"56","author":"Momma","year":"2022","journal-title":"Br J Sports Med"},{"key":"10.1016\/j.diabres.2025.112209_b0130","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1249\/MSS.0000000000001063","article-title":"Strength Training and the Risk of Type 2 Diabetes and Cardiovascular Disease","volume":"49","author":"Shiroma","year":"2017","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.diabres.2025.112209_b0135","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.cgh.2021.12.043","article-title":"Association of Physical Activity With Risk of Liver Fibrosis, Sarcopenia, and Cardiovascular Disease in Nonalcoholic Fatty Liver Disease","volume":"21","author":"Chun","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.diabres.2025.112209_b0140","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1152\/japplphysiol.00053.2005","article-title":"Exercise without weight loss is an effective strategy for obesity reduction in obese individuals with and without Type 2 diabetes","volume":"99","author":"Lee","year":"2005","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.diabres.2025.112209_b0145","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jhep.2024.08.024","article-title":"Frailty and risk of metabolic dysfunction-associated steatotic liver disease and other chronic liver diseases","volume":"82","author":"Zhong","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.diabres.2025.112209_b0150","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/liv.15725","article-title":"Metabolic dysfunction-associated steatotic liver disease in older adults is associated with frailty and social disadvantage","volume":"44","author":"Clayton-Chubb","year":"2024","journal-title":"Liver Int"},{"key":"10.1016\/j.diabres.2025.112209_b0155","doi-asserted-by":"crossref","DOI":"10.1093\/gerona\/glae011","article-title":"Late-Life Metabolic Dysfunction-Associated Steatotic Liver Disease and its Association With Physical Disability and Dementia","volume":"79","author":"Clayton-Chubb","year":"2024","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.diabres.2025.112209_b0160","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/ageing\/afw090","article-title":"Physical activity and incidence of sarcopenia: the population-based AGES\u2014Reykjavik Study","volume":"45","author":"Mijnarends","year":"2016","journal-title":"Age Ageing"},{"key":"10.1016\/j.diabres.2025.112209_b0165","doi-asserted-by":"crossref","first-page":"11488","DOI":"10.1038\/s41598-021-90869-1","article-title":"A cross-sectional study about the relationship between physical activity and sarcopenia in Taiwanese older adults","volume":"11","author":"Ko","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.diabres.2025.112209_b0170","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/hep.28376","article-title":"Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008-2011)","volume":"63","author":"Lee","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.diabres.2025.112209_b0175","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1161\/ATV.0000000000000153","article-title":"Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association","volume":"42","author":"Duell","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.diabres.2025.112209_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.101264","article-title":"Association between sarcopenia and cardiovascular disease among middle-aged and older adults: Findings from the China health and retirement longitudinal study","volume":"44","author":"Gao","year":"2022","journal-title":"EClinicalMedicine"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822725002232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822725002232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T04:51:48Z","timestamp":1778388708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822725002232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":36,"alternative-id":["S0168822725002232"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2025.112209","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of physical activities in metabolic dysfunction associated steatotic liver disease, sarcopenia, and cardiovascular disease","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2025.112209","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112209"}}